Oleksandr Brener

548 total citations
16 papers, 432 citations indexed

About

Oleksandr Brener is a scholar working on Physiology, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Oleksandr Brener has authored 16 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 9 papers in Molecular Biology and 6 papers in Computational Theory and Mathematics. Recurrent topics in Oleksandr Brener's work include Alzheimer's disease research and treatments (14 papers), Computational Drug Discovery Methods (6 papers) and Amino Acid Enzymes and Metabolism (3 papers). Oleksandr Brener is often cited by papers focused on Alzheimer's disease research and treatments (14 papers), Computational Drug Discovery Methods (6 papers) and Amino Acid Enzymes and Metabolism (3 papers). Oleksandr Brener collaborates with scholars based in Germany, United States and France. Oleksandr Brener's co-authors include Dieter Willbold, Luitgard Nagel‐Steger, Janine Kutzsche, Susanne Aileen Funke, Markus Tusche, Inga Kadish, Thomas van Groen, Dirk Bartnik, Lothar Gremer and Tamar Ziehm and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Oleksandr Brener

16 papers receiving 427 citations

Peers

Oleksandr Brener

PHYSI

CTM

PHARM

BIOMA

Dirk Bartnik Germany

Tamar Ziehm Germany

Janine Kutzsche Germany

Eduard Puig Spain

Anna Wahlström Sweden

Diane M. Bartley United States

Alexandra Esteras‐Chopo Germany

Saravanakumar Narayanan Germany

Kelvin Stott United Kingdom

Chendi Zhan China

Dirk Bartnik Germany

Oleksandr Brener

218 ×0.8

PHYSI

270 ×1.0

63 ×0.7

CTM

56 ×0.8

PHARM

62 ×1.1

BIOMA

Citations per year, relative to Oleksandr Brener Oleksandr Brener (= 1×) peers Dirk Bartnik

Countries citing papers authored by Oleksandr Brener

Since Specialization

Citations

This map shows the geographic impact of Oleksandr Brener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oleksandr Brener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oleksandr Brener more than expected).

Fields of papers citing papers by Oleksandr Brener

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oleksandr Brener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oleksandr Brener. The network helps show where Oleksandr Brener may publish in the future.

Co-authorship network of co-authors of Oleksandr Brener

This figure shows the co-authorship network connecting the top 25 collaborators of Oleksandr Brener. A scholar is included among the top collaborators of Oleksandr Brener based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oleksandr Brener. Oleksandr Brener is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Zhao, Yanyan, Oleksandr Brener, Ewa Andrzejewska, et al.. (2024). Detecting and Tracking β-Amyloid Oligomeric Forms and Dynamics In Vitro by a High-Sensitivity Fluorescent-Based Assay. ACS Chemical Neuroscience. 15(24). 4383–4389. 2 indexed citations

Gremer, Lothar, Elke Reinartz, Anna König, et al.. (2018). A d-enantiomeric peptide interferes with heteroassociation of amyloid-β oligomers and prion protein. Journal of Biological Chemistry. 293(41). 15748–15764. 23 indexed citations

Ziehm, Tamar, Markus Tusche, Oleksandr Brener, et al.. (2018). In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer’s Disease. Journal of Alzheimer s Disease. 64(3). 859–873. 10 indexed citations

Groen, Thomas van, Oleksandr Brener, Lothar Gremer, et al.. (2017). The Aβ oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathology. Scientific Reports. 7(1). 16275–16275. 47 indexed citations

Kutzsche, Janine, Markus Tusche, Joerg Neddens, et al.. (2017). Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer’s Disease. Molecules. 22(10). 1693–1693. 29 indexed citations

Klein, Antonia, Tamar Ziehm, Thomas van Groen, et al.. (2017). Optimization of d-Peptides for Aβ Monomer Binding Specificity Enhances Their Potential to Eliminate Toxic Aβ Oligomers. ACS Chemical Neuroscience. 8(9). 1889–1900. 23 indexed citations

Klein, Antonia, Markus Tusche, Christine Schlosser, et al.. (2016). Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity. PLoS ONE. 11(2). e0147470–e0147470. 13 indexed citations

Klein, Antonia, Tamar Ziehm, Markus Tusche, et al.. (2016). Optimization of the All-D Peptide D3 for Aβ Oligomer Elimination. PLoS ONE. 11(4). e0153035–e0153035. 19 indexed citations

Ziehm, Tamar, Oleksandr Brener, Thomas van Groen, et al.. (2016). Increase of Positive Net Charge and Conformational Rigidity Enhances the Efficacy of d-Enantiomeric Peptides Designed to Eliminate Cytotoxic Aβ Species. ACS Chemical Neuroscience. 7(8). 1088–1096. 26 indexed citations

10.

Müller, Henrik, Oleksandr Brener, Olivier Andréoletti, et al.. (2014). Progress towards structural understanding of infectious sheep PrP-amyloid. Prion. 8(5). 344–358. 9 indexed citations

11.

Olubiyi, Olujide O., Dirk Bartnik, Oleksandr Brener, et al.. (2014). Amyloid Aggregation Inhibitory Mechanism of Arginine-rich D-peptides. Current Medicinal Chemistry. 21(12). 1448–1457. 29 indexed citations

12.

Brener, Oleksandr, et al.. (2014). Immobilization of Homogeneous Monomeric, Oligomeric and Fibrillar Aβ Species for Reliable SPR Measurements. PLoS ONE. 9(3). e89490–e89490. 11 indexed citations

13.

Wurm, Reinhild, Oleksandr Brener, Philipp Ellinger, et al.. (2013). Double-strand DNA end-binding and sliding of the toroidal CRISPR-associated protein Csn2. Nucleic Acids Research. 41(12). 6347–6359. 40 indexed citations

14.

Funke, Susanne Aileen, Hongmei Liu, Torsten Sehl, et al.. (2012). Identification and Characterization of an Aβ Oligomer Precipitating Peptide That May Be Useful to Explore Gene Therapeutic Approaches to Alzheimer Disease. Rejuvenation Research. 15(2). 144–147. 8 indexed citations

15.

Müller‐Schiffmann, Andreas, Raik Rönicke, Dirk Bartnik, et al.. (2010). Combining Independent Drug Classes into Superior, Synergistically Acting Hybrid Molecules. Angewandte Chemie International Edition. 49(46). 8743–8746. 45 indexed citations

16.

Funke, Susanne Aileen, Thomas van Groen, Inga Kadish, et al.. (2010). Oral Treatment with the d-Enantiomeric Peptide D3 Improves the Pathology and Behavior of Alzheimer’s Disease Transgenic Mice. ACS Chemical Neuroscience. 1(9). 639–648. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact